WHO ICTRP trial
A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to…
EUCTR2006-003695-35-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-003695-35-SE |
|---|---|
| Public title | A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to Assess the Efficacy and Safety of ZD6474 (ZACTIMA™) in Combination with Pemetrexed (Alimta®) versus Pemetrexed alone in Patients with Locally-Advanced or Metastatic (stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC) after Failure of 1st Line Anti-cancer Therapy |
| Scientific title | A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to Assess the Efficacy and Safety of ZD6474 (ZACTIMA™) in Combination with Pemetrexed (Alimta®) versus Pemetrexed alone in Patients with Locally-Advanced or Metastatic (stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC)… |
| Primary sponsor | AstraZeneca AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Portugal;United Kingdom;Germany;Belgium;France;Spain;Italy;Greece;Sweden |
| Conditions | Locally-advanced or Metastatic (stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC). MedDRA version: 8.1 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS |
| Interventions | Product Name: ZACTIMA Product Code: ZD6474 Pharmaceutical Form: Tablet INN or Proposed INN: vandetanib Current Sponsor code: ZD6474 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- Pharmaceutical form… |
| Registration date | Nov 13, 2006 |
| Target size | 510 |
| Secondary IDs | D4200C00036 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: